Part 22: Alan Burnett, M.D.

Dr. Alan Burnett has a main research interest in the development of treatments for Acute Myeloid Leukemia. He has served on numerous advisory committees and is a past President of the British Society of Haematology and Chair of the UK National Training Programme. Professor Burnett was appointed as Chair of the National Cancer Research Institute Haematological Oncology Study Group. He was elected as a Fellow of the Academy of Medical Science in 2002, was awarded the Gold Medal of the British Society for Haematology in 2004 and gave the prestigious Ham Wasserman Lecture at the American Society of Hematology meeting in 2012. Currently, he is a Professor at the University of Glasgow in Scotland… Read more …